William P. Donnelly
William P. Donnelly's purchase track record
William P. Donnelly has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/12/2026 | QTRX | $286K | pending | pending | — |
| 6/6/2025 | QTRX | $506K | -15.3% | +42.1% | +14.5% |
| 9/8/2023 | QTRX | $502K | -6.1% | +8.2% | +14.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
T. Rowe Price Faces Advisor Hiring Push and Dividend Debate. T. Rowe Price is testing its growth strategy with a new advisor hiring push, while analysts note a modest fair‑value cut amid mixed views. The firm’s dividend yield of 4.97% keeps it in the conversation with other dividend leaders, and a recent 38% share drop has led some to label it undervalued. Earnings expectations are being watched closely as the company prepares its next quarterly report.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Ingersoll Rand News: Growth, Earnings Outlook, and Risk Review. Recent articles highlight Ingersoll Rand’s solid growth but note that analysts have not upgraded the stock. Another piece outlines expectations for the company’s Q3 2026 earnings, while a third review praises its durable economics. A recent risk assessment lists the stock as one of two considered risky among industrials, adding a cautionary note to its profile.
Transaction History
| QTRX | ▲ Buy | Grant | 6,964 | $24K | 10/1/2026 | View on chart |
| TROW | ▲ Buy | Grant | 164 | $17K | 9/29/2026 | View on chart |
| QTRX | ▲ Buy | Option Exercise | 2,802 | — | 8/17/2026 | View on chart |
| QTRX | ▲ Buy | Open Market | 72,245 | $212K | 8/13/2026 | View on chart |
| QTRX | ▲ Buy | Open Market | 27,155 | $75K | 8/12/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 5,472 | $24K | 7/1/2026 | View on chart |
| TROW | ▲ Buy | Grant | 576 | $0 | 6/30/2026 | View on chart |
| TROW | ▲ Buy | Grant | 142 | $16K | 6/29/2026 | View on chart |
| TROW | ▲ Buy | Grant | 1,899 | $0 | 5/8/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 6,178 | $0 | 4/1/2026 | View on chart |
| TROW | ▲ Buy | Grant | 152 | $14K | 3/30/2026 | View on chart |
| IR | ▲ Buy | Option Exercise | 3,029 | — | 2/26/2026 | View on chart |
| QTRX | ▲ Buy | Grant | 2,377 | $0 | 1/2/2026 | View on chart |
| TROW | ▲ Buy | Grant | 621 | $0 | 12/31/2025 | View on chart |
| TROW | ▲ Buy | Grant | 119 | $12K | 12/30/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 5,076 | $28K | 10/1/2025 | View on chart |
| TROW | ▲ Buy | Grant | 117 | $12K | 9/29/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 4,204 | $28K | 7/1/2025 | View on chart |
| TROW | ▲ Buy | Grant | 670 | $0 | 6/30/2025 | View on chart |
| TROW | ▲ Buy | Grant | 116 | $11K | 6/27/2025 | View on chart |
| QTRX | ▲ Buy | Open Market | 93,113 | $506K | 6/6/2025 | View on chart |
| TROW | ▲ Buy | Grant | 2,157 | $0 | 5/9/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 2,681 | $18K | 4/1/2025 | View on chart |
| TROW | ▲ Buy | Grant | 90 | $8K | 3/28/2025 | View on chart |
| IR | ▲ Buy | Option Exercise | 2,793 | — | 2/27/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 7,435 | $0 | 1/2/2025 | View on chart |
| QTRX | ▲ Buy | Grant | 1,282 | $14K | 1/2/2025 | View on chart |
| TROW | ▲ Buy | Grant | 541 | $0 | 12/30/2024 | View on chart |
| TROW | ▲ Buy | Grant | 63 | $7K | 12/27/2024 | View on chart |
| IR | ▼ Sell | Gift | 14,875 | $0 | 12/4/2024 | View on chart |
| QTRX | ▲ Buy | Grant | 1,000 | $13K | 10/1/2024 | View on chart |
| TROW | ▲ Buy | Grant | 66 | $7K | 9/27/2024 | View on chart |
| QTRX | ▲ Buy | Grant | 985 | $12K | 7/1/2024 | View on chart |
| TROW | ▲ Buy | Grant | 560 | $0 | 6/28/2024 | View on chart |
| TROW | ▲ Buy | Grant | 56 | $6K | 6/27/2024 | View on chart |
| TROW | ▲ Buy | Grant | 1,794 | $0 | 5/8/2024 | View on chart |
| QTRX | ▲ Buy | Grant | 525 | $12K | 4/1/2024 | View on chart |
| TROW | ▲ Buy | Grant | 35 | $4K | 3/28/2024 | View on chart |
| IR | ▲ Buy | Option Exercise | 4,059 | — | 2/23/2024 | View on chart |
| QTRX | ▲ Buy | Grant | 2,947 | $0 | 1/2/2024 | View on chart |
| QTRX | ▲ Buy | Grant | 460 | $12K | 1/2/2024 | View on chart |
| TROW | ▲ Buy | Grant | 191 | $21K | 12/29/2023 | View on chart |
| TROW | ▲ Buy | Grant | 36 | $4K | 12/29/2023 | View on chart |
| TROW | ▲ Buy | Grant | 3,182 | $0 | 11/2/2023 | View on chart |
| QTRX | ▲ Buy | Grant | 228 | $6K | 10/2/2023 | View on chart |
| QTRX | ▲ Buy | Open Market | 20,200 | $502K | 9/8/2023 | View on chart |
| QTRX | ▲ Buy | Grant | 8,238 | $0 | 8/17/2023 | View on chart |
| IR | ▲ Buy | Option Exercise | 4,426 | — | 2/22/2023 | View on chart |
| IR | ▲ Buy | Option Exercise | 3,839 | — | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Quanterix Highlights Spatial Biology Innovation at ESSB 2026
Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.
Quanterix Highlights Spatial Biology Innovation at ESSB 2026. Quanterix announced it met its spatial biology content innovation commitments during the ESSB 2026 event. The company showcased new tools and data sets that support advanced spatial analysis. This demonstrates progress in its product roadmap and may strengthen its position in the spatial biology market.